In vivo Patterns of Tau Pathology, Amyloid-β Burden, and Neuronal Dysfunction in Clinical Variants of Alzheimer's Disease

Journal of Alzheimer's Disease

Volumn 55, Issue 2, 2017, Pages 465-471

  Dronse, Julian ^a,b   Fliessbach, Klaus ^c,d   Bischof, Gérard N ^a,b   Von Reutern, Boris ^a,b   Faber, Jennifer ^c,d   Hammes, Jochen ^a   Kuhnert, Georg ^a   Neumaier, Bernd ^a,b   Onur, Oezguer A ^a,b   Kukolja, Juraj ^a,b   Van Eimeren, Thilo ^a,b,d   Jessen, Frank ^a,d   Fink, Gereon R ^a,b   Klockgether, Thomas ^c,d   Drzezga, Alexander ^a,d  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b FORSCHUNGSZENTRUM JÜLICH   (Germany)

^c UNIVERSITY HOSPITAL BONN   (Germany)

^d GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

Author keywords

18F AV 1451; 18F FDG; Alzheimer's disease; amyloid; molecular imaging; multimodal imaging; Pittsburgh compound B; positron emission tomography; T 807; tau protein

Indexed keywords

AMYLOID BETA PROTEIN; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; PITTSBURGH COMPOUND B; TAU PROTEIN; 7-(6-FLUOROPYRIDIN-3-YL)-5H-PYRIDO(4,3-B)INDOLE; CARBOLINE DERIVATIVE;

ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; FRONTAL LOBE; HUMAN; IN VIVO STUDY; NERVE CELL LESION; OCCIPITAL LOBE; PARIETAL LOBE; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN METABOLISM; TAUOPATHY; TEMPORAL LOBE; ATROPHY; BRAIN; COGNITIVE DEFECT; COMPLICATION; CORTICOMEDIAL AMYGDALA; DIAGNOSTIC IMAGING; EXECUTIVE FUNCTION; FEMALE; LANGUAGE DISABILITY; MALE; METABOLISM; NEUROPSYCHOLOGICAL TEST; PATHOLOGY;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ATROPHY; BRAIN; CARBOLINES; COGNITION DISORDERS; CORTICOMEDIAL NUCLEAR COMPLEX; EXECUTIVE FUNCTION; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LANGUAGE DISORDERS; MALE; NEUROPSYCHOLOGICAL TESTS; POSITRON-EMISSION TOMOGRAPHY; TAU PROTEINS;

EID: 84999293137     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-160316     Document Type: Article

References (21)

1. Murray ME, Graff-Radford NR, Ross OA, Petersen RC, Duara R, Dickson DW(2011) Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: A retrospective study. Lancet Neurol 10, 785-796.
2. Crutch SJ, Lehmann M, Schott JM, Rabinovici GD, Rossor MN, Fox NC (2012) Posterior cortical atrophy. Lancet Neurol 11, 170-178.
3. Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, Ogar JM, Rohrer JD, Black S, Boeve BF, Manes F, Dronkers NF, Vandenberghe R, Rascovsky K, Patterson K, Miller BL, Knopman DS, Hodges JR, Mesulam MM, Grossman M (2011) Classification of primary progressive aphasia and its variants. Neurology 76, 1006-1014.
4. Johnson JK, Head E, Kim R, Starr A, Cotman CW (1999) Clinical and pathological evidence for a frontal variant of Alzheimer disease. Arch Neurol 56, 1233-1239.
5. Ossenkoppele R, Pijnenburg YAL, Perry DC, Cohn-Sheehy BI, Scheltens NME, Vogel JW, Kramer JH, van der Vlies AE, Joie RL, Rosen HJ, van der Flier WM, Grinberg LT, Rozemuller AJ, Huang EJ, van Berckel BNM, Miller BL, Barkhof F, Jagust WJ, Scheltens P, Seeley WW, Rabinovici GD (2015) The behavioural/dysexecutive variant of Alzheimer's disease: Clinical, neuroimaging and pathological features. Brain 138, 2732-2749.
6. Lehmann M, Ghosh PM, Madison C, Laforce R, Corbetta-Rastelli C, Weiner MW, Greicius MD, Seeley WW, Gorno-Tempini ML, Rosen HJ, Miller BL, Jagust WJ, Rabinovici GD (2013) Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease. Brain 136, 844-858.
7. Altmann A, Ng B, Landau SM, Jagust WJ, Greicius MD, Alzheimer's Disease Neuroimaging Initiative (2015) Regional brain hypometabolism is unrelated to regional amyloid plaque burden. Brain 138, 3734-3746.
8. Gomez-Isla T, Hollister R, West H, Mui S, Growdon JH, Petersen RC, Parisi JE, Hyman BT (1997) Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol 41, 17-24.
9. Bennett DA, Schneider JA, Wilson RS, Bienias JL, Arnold SE (2004) Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch Neurol 61, 378-384.
10. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82, 239-259.
11. Janocko NJ, Brodersen KA, Soto-Ortolaza AI, Ross OA, Liesinger AM, Duara R, Graff-Radford NR, Dickson DW, MurrayME(2012) Neuropathologically defined subtypes of Alzheimer's disease differ significantly from neurofibrillary tangle-predominant dementia. Acta Neuropathol 124, 681-692.
12. Chien DT, Szardenings AK, Bahri S, Walsh JC, Mu F, Xia C, Shankle WR, Lerner AJ, Su M-Y, Elizarov A, Kolb HC (2014) Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808. J Alzheimers Dis 38, 171-184.
13. Maruyama M, Shimada H, Suhara T, Shinotoh H, Ji B, Maeda J, Zhang M-R, Trojanowski JQ, Lee VMY, Ono M, Masamoto K, Takano H, Sahara N, Iwata N, Okamura N, Furumoto S, Kudo Y, Chang Q, Saido TC, Takashima A, Lewis J, Jang M-K, Aoki I, Ito H, Higuchi M (2013) Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls. Neuron 79, 1094-1108.
14. Marquie M, Normandin MD, Vanderburg CR, Costantino I, Bien EA, Rycyna LG, Klunk WE, Mathis CA, Ikonomovic MD, Debnath ML, Vasdev N, Dickerson BC, Gomperts SN, Growdon JH, Johnson KA, Frosch MP, Hyman BT, Gomez-Isla T (2015) Validating novel tau PET tracer [F-18]-AV-1451 (T807) on postmortem brain tissue. Ann Neurol 78, 787-800.
15. Ossenkoppele R, Schonhaut DR, Baker SL, O'Neil JP, Janabi M, Ghosh PM, Santos M, Miller ZA, Bettcher BM, Gorno-Tempini ML, Miller BL, Jagust WJ, Rabinovici GD (2015) Tau, amyloid, and hypometabolism in a patient with posterior cortical atrophy. Ann Neurol 77, 338-342.
16. Buerger K, Ewers M, Pirttilä T, Zinkowski R, Alafuzoff I, Teipel SJ, DeBernardis J, Kerkman D, McCulloch C, Soininen H, Hampel H (2006) CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease. Brain 129, 3035-3041.
17. Galton CJ, Patterson K, Xuereb JH, Hodges JR (2000) Atypical and typical presentations of Alzheimer's disease: A clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain 123(Pt 3), 484-498.
18. Koedam ELGE, Lauffer V, van der Vlies AE, van der Flier WM, Scheltens P, Pijnenburg YAL (2010) Earlyversus late-onset Alzheimer's disease: More than age alone. J Alzheimers Dis 19, 1401-1408.
19. Snowden JS, Stopford CL, Julien CL, Thompson JC, Davidson Y, Gibbons L, Pritchard A, Lendon CL, Richardson AM, Varma A, Neary D, Mann D (2007) Cognitive phenotypes in Alzheimer's disease and genetic risk. Cortex 43, 835-845.
20. Duits FH, Teunissen CE, Bouwman FH, Visser P-J, Mattsson N, Zetterberg H, Blennow K, Hansson O, Minthon L, Andreasen N, Marcusson J, Wallin A, Rikkert MO, Tsolaki M, Parnetti L, Herukka S-K, Hampel H, De Leon MJ, Schröder J, Aarsland D, Blankenstein MA, Scheltens P, van der Flier WM (2014) The cerebrospinal fluid "Alzheimer profile": Easily said, but what does it mean? Alzheimers Dement 10, 713-723.e2.
21. Ossenkoppele R, Schonhaut DR, Schöll M, Lockhart SN, Ayakta N, Baker SL, O'Neil JP, Janabi M, Lazaris A, Cantwell A, Vogel J, Santos M, Miller ZA, Bettcher BM, Vossel KA, Kramer JH, Gorno-Tempini ML, Miller BL, Jagust WJ, Rabinovici GD (2016) Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. Brain 139, 1551-1567.